[1]
|
I. Y. Galaev and B. Mattiasson, “Smart Polymers and What They Could Do in Biotechnology and Medicine,” Trends in Biotechnology, Vol. 17, No. 8, 1999, pp. 335- 340. doi:10.1016/S0167-7799(99)01345-1
|
[2]
|
O. Pillail and R. Panchagnula, “Polymers in Drug Delivery,” Current Opinion in Chemical Biology, Vol. 5, No. 4, 2001, pp. 447-451. doi:10.1016/S1367-5931(00)00227-1
|
[3]
|
S. Li, “Hydrolytic Degradation Characteristics of Aliphatic Polyesters Derived from Lactic and Glycolic Acids,” Journal of Biomedical Materials Research, Vol. 48, No. 3, 1999, pp. 342-53.
doi:10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
|
[4]
|
A. S. Hoffman, “Hydrogels for Biomedical Application,” Advanced Drug Delivery Reviews, Vol. 54, No. 1, 2002, pp. 3-12. doi:10.1016/S0169-409X(01)00239-3
|
[5]
|
R. Chera and R. Rustgi, “Biodegradable Polymers,” Progress in Polymer Science, Vol. 23, No. 7, 1998, pp. 1273- 1335. doi:10.1016/S0079-6700(97)00039-7
|
[6]
|
O. Seigo, “Application of Superabsorbent Polymers in Japanese Agriculture and Greening, Gels Handbook,” Academic Press, Waltham, 2001.
|
[7]
|
R. Langer and N. A. Peppas, “Advances in Biomaterials, Drug Delivery, and Bion-anotechnology,” AlChE Journal, Vol. 49, No. 12, 2003, pp. 2990-3006.
doi:10.1002/aic.690491202
|
[8]
|
M. Chasin and R. Langer, “Biodegradable Polymers as Drug Delivery Systems,” McGraw-Hill, New York, 1990.
|
[9]
|
C. E. Soma, C. Dubernet, D. Bentolila, S. Benita and P. Couvreur, “Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Cyclosporin A in Polyalkyl-cyanoacrylate Nanoparticles,” Biomaterials, Vol. 21, No. 1, 2000, pp. 1-7. doi:10.1016/S0142-9612(99)00125-8
|
[10]
|
R. A. Jain, “The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Devices,” Biomaterials, Vol. 21, No. 23, 2000, pp. 2475-2490. doi:10.1016/S0142-9612(00)00115-0
|
[11]
|
V. Michel, “Polymeric Biomaterials: Strategies of the Past vs. Strategies of the Future,” Progress in Polymer Science, Vol. 32, No. 8-9, 2007, pp. 755-761.
doi:10.1016/j.progpolymsci.2007.05.006
|
[12]
|
L. Xiaoling and R. J. Haskara, “Design of Controlled Release Drug Delivery Systems,” MacGraw-Hill, New York, 2006.
|
[13]
|
N. Angelova and D. Hunkeler, “Rationalizing the Design of Polymeric Biomaterials,” Trends in Biotechnology, Vol. 17, No. 10, 1999, pp. 409-421.
doi:10.1016/S0167-7799(99)01356-6
|
[14]
|
M. M. M. El-nashar, “Review Article: Immobilized Mole- cules Using Biomaterials and Nanobiotechnology,” Jour- nal of Bio-materials and Nanobiotechnology, Vol. 1, No. 1, 2010, pp. 61-77. doi:10.4236/jbnb.2010.11008
|
[15]
|
A. Q. Soares, L. F. Oliveira, D. Rabelo and A. R. Souza, “Polímeros Biodegradáveis: Novas Perspectivas Para as Ciências Farmacêuticas,” Revista Eletr?nica de Farmácia, Vol. 2, No. 2, 2005, pp. 202-205.
|
[16]
|
M. L. Hans and A. M. Lowman, “Biodegradable Nanoparticles for Drug Delivery and Targeting,” Current Opinion in Solid State and Materials Science, Vol. 6, No. 4, 2002, pp. 319-327. doi:10.1016/S1359-0286(02)00117-1
|
[17]
|
Q. Cai, G. Shi, J. Bei and S. Wang, “Enzymatic Degradation Behavior and Mechanism of Poly(Lactide-Co-Glycolide) Foams by Trypsin,” International Journal of Pharmaceutics, Vol. 24, No. 4, 2003, pp. 629-638.
|
[18]
|
J. Lunt, “Large-scale Production, Properties and Commercial Applications of Polylactic Acid Polymers,” Polymer Degradation and Stability, Vol. 59, No. 1-3, 1998, pp. 145-152. doi:10.1016/S0141-3910(97)00148-1
|
[19]
|
H. Fukuzaki, M. Yoshida, M. Asano and M. Kumakura, “Synthesis of copoly(D,L-Lactic Acid) with Relatively Low Molecular Weight and in Vivo Degradation,” European Polymer Journal, Vol. 25, No. 10, 1989, pp. 1019-1026. doi:10.1016/0014-3057(89)90131-6
|
[20]
|
D. K. Gilding and A. M. Reed, “Biodegradable Polymers for Use in Surgery Polyglycolid/Poly(Lactic Acid) Homo and Copolymers,” Polymer, Vol. 20, No. 12, 1979, pp. 1459-1464. doi:10.1016/0032-3861(79)90009-0
|
[21]
|
D. Bendix, “Chemical Synthesis of Polylactide and Its Copolymers for Medical Applications,” Polymer Degradation and Stability, Vol. 59, No. 1-3, 1998, pp. 129-135.
doi:10.1016/S0141-3910(97)00149-3
|
[22]
|
P. B. Deasy, M. P. Finan and M. J. Meegan, “Preparation and Characterization of Lactic/Glycolic Acid Polymers and Copolymers,” Journal of Microencapsulation, Vol. 6, No. 3, 1989, pp. 369-378.
|
[23]
|
C. Jé?me and P. Lecomte, “Recent Advances in the Synthesis of Aliphatic Polyesters by Ring-Opening Polym- erization,” Advanced Drug Delivery Reviews, Vol. 60, No. 9, 2008, pp. 1056-1076.
doi:10.1016/j.addr.2008.02.008
|
[24]
|
B. D. Ratner and A. S. Hoffman, “Biomaterials Science— An Introduction to Materials in Medicine,” Elsevier Academic Press, Waltham, 1996.
|
[25]
|
M. J. Blanco-Prieto, E. Fattal, F. Puisieux and P. Couvreur, “The Multiple Emulsion as a Common Step for the Design of Polymeric Microparticles,” In: J. L. Grossiord and M. Seiller, Eds., Multiple emulsions: Structure, Properties and Applications, éditions de Santé, Paris, 1998, pp. 397-435.
|
[26]
|
D. H Lewis, “Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers,” In: M. Chasin and R. Langer, Eds., Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1-41.
|
[27]
|
S. L. Fialho, M. G. B. Rego, J. A. Cardillo, R. C. Siqueira, R. Jorge and A. S. Cunha Jr., “Implantes Biodegradáveis Destinados à Administra??o Intra-Ocular,” Arquivos Brasileiros de Oftalmologia, Vol. 66, No. 6, 2003, pp. 891- 896. doi:10.1590/S0004-27492003000700029
|
[28]
|
A. Merkli, C. Tabatabay, R. Gurny and J. Heller, “Biodegradable Polymers for the Controlled Release of Ocular Drugs,” Progress in Polymer Science, Vol. 23, No. 3, 1998, pp. 563-580. doi:10.1016/S0079-6700(97)00048-8
|
[29]
|
K. A. Athanasiou, G. G. Niederauer and C. M. Agrawal, “Sterilization, Toxicity, Biocompatibility and Clinical Applications of Polylactic Acid/Polyglycolic Acid Copolymers”, Biomaterials, Vol. 17, No. 2, 1996, pp. 93-102.
doi:10.1016/0142-9612(96)85754-1
|
[30]
|
M. Kiremit?i-Gümüsderelioglu and G. Deniz, “Synthesis, Characterization and in Vitro Degradation of Poly(D,L- Lactide)/Poly(D,L-Lactide-Co-Glycolide),” Turkish Journal of Chemistry, Vol. 23, No. 2, 1999, pp. 153-161.
|
[31]
|
X. Kaitian, A. Kozluca, E. B. Denkbas and E. Piskin, “Poly(D,L-lactic acid) Homopolymers: Synthesis and Characterization,” Turkish Journal of Chemistry, Vol. 20, No. 1, 1996, pp. 43-53.
|
[32]
|
E. Jabbari, E. Xuezhong, “Synthesis and Characterization of Bioresorbable in Situ Crosslinkable Ultra Low Molecular Weight Poly(Lactide) Macromere,” Journal of Materials Science: Materials in Medicine, Vol. 19, No. 1, 2008, pp. 311-317. doi:10.1007/s10856-006-0020-2
|
[33]
|
V. Kumar and G. S. Banker, “Chemically-Modified Cellulosic Polymers,” Drug Development and Industrial Pharmacy, Vol. 19, No. 1, 1993, pp. 1-31.
|
[34]
|
A. A. Silva Jr., J. R. Matos, T. P. Formariz, G. Rossanezi, M. V. Scarpa, E. S; T. Egito and A. G. Oliveira, “Thermal Behavior and Stability of Biodegradable Spray-Dried Microparticles Containing Triamcinolone,” International Journal of Pharmaceutics, Vol. 368, No. 1-2, 2009, pp. 45-55.
|
[35]
|
R. Lindhardt, “Polímeros Biodegradáveis Para Libera??o Controlada de Droga,” Springer-Verlag, Now York, 1998.
|
[36]
|
A. G. Hausberger and P. P. DeLuca, “Characterization of Biodegradable Poly(D,L-Lactide-Co-Glycolide) Polymers and Microparticles,” Journal of Pharmaceutical and Bio- medical Analysis, Vol. 13, No. 6, 1995, pp. 747-760.
doi:10.1016/0731-7085(95)01276-Q
|
[37]
|
N. B. Colthup, L. H. Daly and S. E. Wiberley, “Introduction to Infrared and Raman Spectroscopy,” 2nd Edition, Academic Press, New York, 1975.
|
[38]
|
D. O. Hummel, “Atlas of Polymer and Plastics Analysis,” Wiley, New York, 2001.
|
[39]
|
J. C. Middleton and A. J. Tipton, “Synthetic Biodegradable Polymers as Medical Devices,” Medical Plastics and Biomaterials Magazine, Vol. 3-4, 1998, pp. 31-38.
|